The cardiovascular and renal effects of glucagon-like peptide 1 receptor agonists in patients with advanced diabetic kidney disease

To determine whether glucagon-like peptide 1 receptor agonists (GLP-1RAs) have cardiovascular and renal protective effects in patients with advanced diabetic kidney disease (DKD) with an estimated glomerular filtration rate (eGFR) 

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cardiovascular Diabetology 2023-03, Vol.22 (1), p.60-60, Article 60
Hauptverfasser: Lin, Yuan, Wang, Te-Hsiung, Tsai, Ming-Lung, Wu, Victor Chien-Chia, Tseng, Chin-Ju, Lin, Ming-Shyan, Li, Yan-Rong, Chang, Chih-Hsiang, Chou, Tien-Shin, Tsai, Tzu-Hsien, Yang, Ning-I, Hung, Ming-Jui, Chen, Tien-Hsing
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:To determine whether glucagon-like peptide 1 receptor agonists (GLP-1RAs) have cardiovascular and renal protective effects in patients with advanced diabetic kidney disease (DKD) with an estimated glomerular filtration rate (eGFR) 
ISSN:1475-2840
1475-2840
DOI:10.1186/s12933-023-01793-9